LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

LLY

1,020.07

-1.55%↓

JNJ

244.95

+0.71%↑

ABBV

228.53

-1.79%↓

NVS

165.17

-0.6%↓

MRK

121.6

+0.04%↑

Search

Integra LifeSciences Holdings Corp

Închisă

SectorSănătate

11.98 4.81

Rezumat

Modificarea prețului

24h

Curent

Minim

11.24

Maxim

12.1

Indicatori cheie

By Trading Economics

Venit

479M

-5.4M

Vânzări

-14M

402M

Marjă de profit

-1.344

Angajați

4,396

EBITDA

526M

54M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+14.84% upside

Dividende

By Dow Jones

Următoarele câștiguri

26 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-374M

882M

Deschiderea anterioară

7.17

Închiderea anterioară

11.98

Sentimentul știrilor

By Acuity

50%

50%

165 / 351 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

18 feb. 2026, 22:31 UTC

Câștiguri

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18 feb. 2026, 22:18 UTC

Câștiguri

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18 feb. 2026, 22:11 UTC

Câștiguri

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18 feb. 2026, 21:52 UTC

Câștiguri

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18 feb. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18 feb. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18 feb. 2026, 23:34 UTC

Market Talk
Câștiguri

Brambles' Cost Control Stands Out to Bull -- Market Talk

18 feb. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18 feb. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18 feb. 2026, 22:45 UTC

Câștiguri

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18 feb. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18 feb. 2026, 22:37 UTC

Câștiguri

Nutrien 4Q EPS $1.18 >NTR.T

18 feb. 2026, 22:37 UTC

Câștiguri

Nutrien 4Q Sales $5.34B >NTR.T

18 feb. 2026, 22:35 UTC

Câștiguri

Pan American Silver 4Q EPS $1.07 >PAAS

18 feb. 2026, 22:35 UTC

Câștiguri

Pan American Silver 4Q Rev $1.18B >PAAS

18 feb. 2026, 22:30 UTC

Câștiguri

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18 feb. 2026, 22:29 UTC

Câștiguri

Kinross Gold 4Q EPS 75c >K.T

18 feb. 2026, 22:22 UTC

Câștiguri

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18 feb. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18 feb. 2026, 22:16 UTC

Câștiguri

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18 feb. 2026, 22:05 UTC

Câștiguri

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18 feb. 2026, 22:03 UTC

Câștiguri

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18 feb. 2026, 22:02 UTC

Câștiguri

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18 feb. 2026, 22:02 UTC

Câștiguri

Kaiser Aluminum 4Q Sales $929M >KALU

18 feb. 2026, 22:02 UTC

Câștiguri

Kaiser Aluminum 4Q EPS $1.68 >KALU

18 feb. 2026, 22:00 UTC

Câștiguri

Kinross Gold 4Q Adj EPS 67c >KGC

18 feb. 2026, 22:00 UTC

Câștiguri

Kinross Gold 4Q Sales $2.02B >KGC

18 feb. 2026, 21:56 UTC

Câștiguri

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18 feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Comparație

Modificare preț

Integra LifeSciences Holdings Corp Așteptări

Obiectiv de preț

By TipRanks

14.84% sus

Prognoză pe 12 luni

Medie 13 USD  14.84%

Maxim 13 USD

Minim 13 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIntegra LifeSciences Holdings Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

12.75 / 16.41Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Weak Bearish Evidence

Sentiment

By Acuity

165 / 351 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat